Phenotypic heterogeneity and evolution of melanoma cells associated with targeted therapy resistance

被引：0
|
作者：
Su, Yapeng [1 ,2 ]
Bintz, Marcus [3 ]
Yang, Yezi [3 ]
Robert, Lidia [4 ]
Ng, Alphonsus H. C. [1 ,2 ]
Liud, Victoria [2 ]
Ribas, Antoni [3 ,4 ,5 ,6 ]
Heath, James R. [1 ,2 ,6 ]
Wei, Wei [1 ,3 ,6 ]
机构：
[1] Institute for Systems Biology, Seattle,WA, United States
[2] Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena,CA, United States
[3] Department of Molecular and Medical Pharmacology, University of California – Los Angeles, Los Angeles,CA, United States
[4] Department of Medicine, University of California – Los Angeles, Los Angeles,CA, United States
[5] Department of Surgery, Division of Surgical-Oncology, University of California – Los Angeles, Los Angeles,CA, United States
[6] Jonsson Comprehensive Cancer Center, University of California – Los Angeles, Los Angeles,CA, United States
来源：
PLoS Computational Biology | 2019年 / 15卷 / 06期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Phenotypic heterogeneity and evolution of melanoma cells associated with targeted therapy resistance
    Su, Yapeng
    Bintz, Marcus
    Yang, Yezi
    Robert, Lidia
    Ng, Alphonsus H. C.
    Liu, Victoria
    Ribas, Antoni
    Heath, James R.
    Wei, Wei
    PLOS COMPUTATIONAL BIOLOGY, 2019, 15 (06)
  • [2] Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance
    Ahmed, Farzana
    Haass, Nikolas K.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [3] Tumour heterogeneity and therapy resistance in melanoma
    Wellbrock, Claudia
    CANCER RESEARCH, 2015, 75
  • [4] PHENOTYPIC HETEROGENEITY OF MELANOMA
    RUITER, DJ
    BROCKER, EB
    VENNEGOOR, C
    FERRONE, S
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 : S23 - &
  • [5] Targeted Therapy in Melanoma and Mechanisms of Resistance
    Czarnecka, Anna M.
    Bartnik, Ewa
    Fiedorowicz, Michal
    Rutkowski, Piotr
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (13) : 1 - 21
  • [6] Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance
    Raaijmakers, Marieke I. G.
    Widmer, Daniel S.
    Narechania, Apurva
    Eichhoff, Ossia
    Freiberger, Sandra N.
    Wenzina, Judith
    Cheng, Phil F.
    Mihic-Probst, Daniela
    Desalle, Rob
    Dummer, Reinhard
    Levesque, Mitchell P.
    ONCOTARGET, 2016, 7 (47) : 77163 - 77174
  • [7] Molecular alterations associated with acquired resistance to BRAFV600E targeted therapy in melanoma cells
    Szasz, Istvan
    Koroknai, Viktoria
    Kiss, Timea
    Vizkeleti, Laura
    Adany, Roza
    Balazs, Margit
    MELANOMA RESEARCH, 2019, 29 (04) : 390 - 400
  • [8] PHENOTYPIC HETEROGENEITY OF MELANOMA - RELATION TO THE DIFFERENTIATION PROGRAM OF MELANOMA-CELLS
    HOUGHTON, AN
    REAL, FX
    DAVIS, LJ
    CORDONCARDO, C
    OLD, LJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (03): : 812 - 829
  • [9] Adipocytes contribute to resistance of human melanoma cells to chemotherapy and targeted therapy
    Chi, Mengna
    Chen, Jiezhong
    Ye, Yan
    Tseng, Hsin-Yi
    Lai, Fritz
    Tay, Kwang Hong
    Jin, Lei
    Jiang, Chen Chen
    Zhang, Xu Dong
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [10] Adipocytes Contribute to Resistance of Human Melanoma Cells to Chemotherapy and Targeted Therapy
    Chi, M.
    Chen, J.
    Ye, Y.
    Tseng, Hsin-Yi
    Lai, F.
    Tay, K. H.
    Jin, L.
    Guo, S. T.
    Jiang, C. C.
    Zhang, X. D.
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (10) : 1255 - 1267
12345